Fishfa Biogenics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 72.63%
- Ebitda 92.82%
- Net Worth -2.20%
- Total Assets -1.54%
About Fishfa Biogenics
Fishfa Biogenics Limited (FBL) is a Public Limited Indian Non-Government Company incorporated in India on 28 March 2019 (Five years and ten months 27 days old ). Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pintu Kalavadia, Prashant Kalavadia, and Umang Savani serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24234GJ2019PLC107295
- Company No.
107295
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Fishfa Biogenics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pintu Kalavadia  | Director | 28-Mar-2019 | Current |
| Prashant Kalavadia | Director | 28-Mar-2019 | Current |
| Umang Savani | Director | 28-Mar-2019 | Current |
Financial Performance of Fishfa Biogenics.
Fishfa Biogenics Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 72.63% increase in profit. The company's net worth dipped by a decrease of 2.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fishfa Biogenics?
In 2021, Fishfa Biogenics had a promoter holding of 69.00% and a public holding of 31.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fishfa Rubbers LimitedPintu Kalavadia, Prashant Kalavadia and 1 more are mutual person
Fishfa World Trade LimitedPintu Kalavadia, Prashant Kalavadia and 1 more are mutual person
- Sheer Agri World Private Limited
Umang Savani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fishfa Biogenics?
Unlock and access historical data on people associated with Fishfa Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fishfa Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fishfa Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.